Association between adherence measurements of metoprolol and health care utilization in older patients with heart failure.
OBJECTIVE
Data from electronic dosing monitors and published pharmacokinetic parameters were used to derive medication adherence measures for immediate-release metoprolol and examine their association with health care utilization of outpatients aged 50 years or older with heart failure.


METHODS
We used a 1-compartment model and published population pharmacokinetic parameters to estimate mean plasma metoprolol concentrations for patients treated for 6 to 12 months. In the absence of directly measured plasma concentrations, we calculated the intended mean plasma concentration (Cp'(ave)) under the assumption of perfect adherence to the prescribed dose and frequency of administration. Projected mean plasma concentrations (Cp(ave)) were estimated by use of data from recorded dosing times. In addition to taking adherence (percentage of dose taken) and scheduling adherence (percentage of doses taken on schedule), we calculated the deviation from the intended exposure (DeltaCp(ave) = Cp'(ave) - Cp(ave)) and the proportion of intended exposure achieved by the patient (Cp(ave) /Cp'(ave)). We assessed the association between the adherence measures and the numbers of emergency department visits and hospital admissions experienced by the patients.


RESULTS
Patients (N = 80) were aged 62 +/- 8 years. Mean DeltaCp(ave) and Cp(ave)/Cp'(ave) were 7.9 ng/mL (SD, 10.7) and 0.6 (SD, 0.3), respectively. Log-linear models adjusted for patient functional status indicated that greater deviation from the intended metoprolol exposure (DeltaCp(ave)) was associated with increased numbers of emergency department visits ( P < .0001) and hospital admissions (P < .0001). A higher proportion of intended exposure (Cp(ave) /Cp'(ave)) corresponded to a reduced number of emergency department visits (P = .0204) and hospital admissions (P = .0093). Taking adherence was univariately associated with both emergency department visits and hospital visits (P < .0001 and P = .0010, respectively). Scheduling adherence was associated with the number of emergency department visits (P = .0181) but not with the number of hospital admissions (P = .1602). Model selection procedures consistently chose the proposed measures over taking adherence and scheduling adherence.


CONCLUSIONS
Deviation from the intended exposure and proportion of intended exposure achieved by the patient are valid adherence measures for immediate-release metoprolol and are associated with health care utilization. The potential utility of these measures for other beta-adrenergic antagonists and perhaps other cardiovascular drugs should be investigated.
Tu
Wanzhu
W
Department of Medicine, Indiana University School of Medicine, Indiannapolis, USA.
Morris
Andrew B
AB
Li
Jingjin
J
Wu
Jingwei
J
Young
James
J
Brater
D Craig
DC
Murray
Michael D
MD
D000368:Aged; D000465:Algorithms; D002317:Cardiovascular Agents / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D004304:Dosage Forms; D004636:Emergency Service, Hospital / Q000706:statistics & numerical data; D005260:Female; D006299:Health Services for the Aged / Q000706:statistics & numerical data*; D006333:Heart Failure / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008790:Metoprolol / Q000494:pharmacology* / Q000627:therapeutic use; D008875:Middle Aged; D010343:Patient Admission / Q000706:statistics & numerical data; D010349:Patient Compliance / Q000706:statistics & numerical data*; D010599:Pharmacokinetics
D002317:Cardiovascular Agents; D004304:Dosage Forms; D008790:Metoprolol
Circulation. 1973 Jan;47(1):76-8
4686606
Lancet. 1975 May 31;1(7918):1205-7
48832
Clin Pharmacol Ther. 1982 Jan;31(1):8-15
7053309
Br J Clin Pharmacol. 1982;13(Suppl 2):345S-351S
6125187
Ann Intern Med. 1984 Feb;100(2):258-68
6362512
J Gen Intern Med. 1987 Sep-Oct;2(5):298-305
3655955
Arch Intern Med. 1988 Sep;148(9):2013-6
3046541
JAMA. 1990 Mar 23-30;263(12):1653-7
1968518
Arch Intern Med. 1990 Sep;150(9):1881-4
2102668
Clin Pharmacol Ther. 1990 Dec;48(6):676-85
2147405
Clin Pharmacokinet. 1992 Mar;22(3):238-46
1559314
Stat Med. 2004 Feb 28;23(4):531-44
14755387
J Am Med Inform Assoc. 2003 Jul-Aug;10(4):389-98
12668695
Eur J Clin Pharmacol. 1993;45(3):211-5
8276043
Stat Methods Med Res. 1999 Sep;8(3):247-62
10636337
Eur J Heart Fail. 2001 Jun;3(3):351-7
11378007
J Clin Epidemiol. 2001 Jun;54(6):619-26
11377123
Am J Geriatr Pharmacother. 2004 Mar;2(1):53-65
15555479
Med Care. 1999 Sep;37(9):846-57
10493464
Arch Intern Med. 1994 Feb 28;154(4):433-7
8117176
Eur Heart J. 1996 Mar;17 Suppl A:8-15
8737195
Clin Pharmacokinet. 1997 May;32(5):345-56
9160169
Int J Med Inform. 1999 Jun;54(3):225-53
10405881
Chirality. 1999;11(7):591-7
10423287